Co-Occurring Symptoms Contribute to Persistent Fatigue in Prostate Cancer
Conclusions: Persistent fatigue at 1 year after EBRT in prostate cancer survivors is likely related to a cluster of symptoms elicited by chronic inflammation. Therapies that target each of these symptoms will likely reduce fatigue in this patient population.Oncology
Source: Oncology - Category: Cancer & Oncology Source Type: research
More News: Cancer | Cancer & Oncology | Cancer Therapy | Chronic Pain | Depression | External Beam Therapy | Pain | Prostate Cancer | Radiation Therapy | Sleep Disorders | Sleep Medicine | Urology & Nephrology